Dark Classics in Chemical Neuroscience: Mescaline
Open accessThe DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Abstract
Archeological studies in the United States, Mexico, and Peru suggest that mescaline, as a cactus constituent, has been used for more than 6000 years. Although it is a widespread cactus alkaloid, it is present in high concentrations in few species, notably the North American peyote ( Lophophora williamsii ) and the South American wachuma ( Trichocereus pachanoi, T. peruvianus, and T. bridgesii ). Spanish 16th century chroniclers considered these cacti “diabolic”, leading to their prohibition, but their use persisted to our days and has been spreading for the last 150 years. In the late 1800s, peyote attracted scientific attention; mescaline was isolated, and its role in the psychedelic effects of peyote tops or “mescal buttons” was demonstrated. Its structure was established by synthesis in 1929, and alternative routes were developed, providing larger amounts for pharmacological and biosynthetic research. Although its effects are attributed mainly to its action as a 5-HT 2A serotonin receptor agonist, mescaline binds in a similar concentration range to 5-HT 1A and α 2A receptors. It is largely excreted unchanged in human urine, and its metabolic products are apparently unrelated to its psychedelic properties. Its low potency is probably responsible for its relative neglect by recreational substance users, as the successful search for structure–activity relationships in the hallucinogen field focused largely on finding more potent analogues. Renewed interest in the possible therapeutic applications of psychedelic drugs may hopefully lead to novel insights regarding the commonalities and differences between the actions of individual classic hallucinogens.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mescaline (6) binds with rather low affinity (Ki) as an agonist at 5HT1A sites (5 µM), 5HT2A/C (6 µM against [3H]-ketanserin), alpha2 (1.4 µM) and TAAR1 (3.3 µM) receptors [9,43].”
From Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans. (2021) · cites this paper as [43]
Citations
Cites
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201
Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698
Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30065-7 · Cited by 1,540
Handbook of Psychopharmacology
(1978) · Springer eBooks · doi:10.1007/978-1-4613-4042-3 · Cited by 1,091
Leysen, J. E., Niemegeers, C. J., Van Nueten, J. M., & Laduron, P. M. (1982) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14623-3 · Cited by 1,071
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
Carhart-Harris, R. L., Bolstridge, M., Day, C. M. J., Rucker, J., Watts, R., Erritzoe, D. E., Kaelen, M., Giribaldi, B., Bloomfield, M., Pilling, S., et al. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4771-x · Cited by 970
Neural correlates of the LSD experience revealed by multimodal neuroimaging
Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., Tagliazucchi, E., Schenberg, E. E., Nest, T., Orban, C., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518377113 · Cited by 859
Gasser, P., Holstein, D., Michel, Y., Doblin, R., Yazar-Klosinski, B., Passie, T., & Brenneisen, R. (2014) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000000113 · Cited by 750
Nichols, D. E. (1986) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1986.10472362 · Cited by 563
Preller, K. H., Herdener, M., Pokorny, T., Planzer, A., Kraehenmann, R., Stämpfli, P., Liechti, M. E., Seifritz, E., & Vollenweider, F. X. (2017) · Current Biology · doi:10.1016/j.cub.2016.12.030 · Cited by 402
A REVIEW OF THE CLINICAL EFFECTS OF PSYCHOTOMIMETIC AGENTS
Osmond, H. (1957) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1957.tb40738.x · Cited by 365 · cited 1×
“(126) Osmond, H. (1957) A review of the clinical effects of psychotomimetic agents.”
BackgroundFortschritte Der Chemie Organischer Naturstoffe
Cormier, M. J., Flasch, H., Franck, B., Hori, K., Jaenicke, L., Keller-Schierlein, W., Locksley, H. D., Müller, D. G., Polonsky, J., Tschesche, R., et al. (1973) · Springer eBooks · doi:10.1007/978-3-7091-7102-8 · Cited by 349
Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways
López-Giménez, J. F., & González-Maeso, J. (2017) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2017_478 · Cited by 299
A possible correlation between drug-induced hallucinations in man and a behavioural response in mice
Corne, S. J., & Pickering, R. W. (1967) · Psychopharmacologia · doi:10.1007/bf00401509 · Cited by 271
Flesh of the Gods : The Ritual Use of Hallucinogens
Furst, P. T. (1972) · Cited by 260
Structure–Activity Relationships of One-Ring Psychotomimetics
SHULGIN, A. T., SARGENT, T., & NARANJO, C. (1969) · Nature · doi:10.1038/221537a0 · Cited by 244
Modern clinical research on LSD
Liechti, M. E. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.86 · Cited by 236
Schultes, R. E. (1969) · Science · doi:10.1126/science.163.3864.245 · Cited by 226
Braden, M. R., Parrish, J. C., Naylor, J. C., & Nichols, D. E. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.028720 · Cited by 215
Rickli, A., Luethi, D., Reinisch, J., Buchy, D., Hoener, M. C., & Liechti, M. E. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.08.034 · Cited by 215
Der Meskalinrausch: Seine Geschichte und Erscheinungsweise
Beringer, K. (1927) · Monographien aus dem Gesamtgebiete der Neurologie und Psychiatrie · doi:10.1007/978-3-662-11451-3 · Cited by 211
The enzymic cleavage of aromatic ethers
Axelrod, J. (1956) · Biochemical Journal · doi:10.1042/bj0630634 · Cited by 193
Hermle, L., Fünfgeld, M., Oepen, G., Botsch, H., Borchardt, D., Gouzoulis, E., Fehrenbach, R. A., & Spitzer, M. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90059-9 · Cited by 182
Unifying Theories of Psychedelic Drug Effects
Swanson, L. R. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00172 · Cited by 181
5-HT2A and 5-HT2C Receptors Exert Opposing Effects on Locomotor Activity in Mice
Halberstadt, A. L., van der Heijden, I., Ruderman, M. A., Risbrough, V. B., Gingrich, J. A., Geyer, M. A., & Powell, S. B. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.29 · Cited by 176
El-Seedi, H. R., Smet, P. A. G. M. D., Beck, O., Possnert, G., & Bruhn, J. G. (2005) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2005.04.022 · Cited by 163
Animal Models of Serotonergic Psychedelics
Hanks, J. B., & González-Maeso, J. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn300138m · Cited by 156
Forstmann, M., & Sagioglou, C. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117714049 · Cited by 156
Psychedelic Drugs in Biomedicine
Kyzar, E. J., Nichols, C. D., Gainetdinov, R. R., Nichols, D. E., & Kalueff, A. V. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.08.003 · Cited by 155
2,5-Dimethoxy-4-methyl-amphetamine (STP): A New Hallucinogenic Drug
Snyder, S. H., Faillace, L. A., & Hollister, L. E. (1967) · Science · doi:10.1126/science.158.3801.669 · Cited by 146
Increased thalamic resting‐state connectivity as a core driver of LSD‐induced hallucinations
Müller, F., Lenz, C., Dolder, P., Lang, U., Schmidt, A., Liechti, M., & Borgwardt, S. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12818 · Cited by 137
Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects
Mueller, F., Lenz, C., Dolder, P. C., Harder, S., Schmid, Y., Lang, U. E., Liechti, M. E., & Borgwardt, S. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.54 · Cited by 127
Synthesis and Structure–Activity Relationships of N-Benzyl Phenethylamines as 5-HT2A/2CAgonists
Hansen, M., Phonekeo, K., Paine, J. S., Leth-Petersen, S., Begtrup, M., Bräuner-Osborne, H., & Kristensen, J. L. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn400216u · Cited by 126
Moya, P. R., Berg, K. A., Gutierrez-Hernandez, M., Sáez‐Briones, P., Reyes-Parada, M. I., Cassels, B. K., & Clarke, W. P. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.117507 · Cited by 115
Self-citationMcLean, T. H., Parrish, J. C., Braden, M. R., Marona-Lewicka, D., Gallardo-Godoy, A., & Nichols, D. E. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060656o · Cited by 115
5HT-2 mediation of acute behavioral effects of hallucinogens in rats
Wing, L. L., Tapson, G. S., & Geyer, M. A. (1990) · Psychopharmacology · doi:10.1007/bf02244617 · Cited by 107
Effect of Hallucinogens on Unconditioned Behavior
Halberstadt, A. L., & Geyer, M. A. (2016) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2016_466 · Cited by 106
Bruhn, J. G., Smet, P. A. G. M. D., El-Seedi, H. R., & Beck, O. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08701-9 · Cited by 104
Oxidation of amines by animal tissues
Pugh, C. E. M., & Quastel, J. H. (1937) · Biochemical Journal · doi:10.1042/bj0312306 · Cited by 103
Dihydrobenzofuran Analogues of Hallucinogens. 4. Mescaline Derivatives
Monte, A. P., Waldman, S. R., Marona-Lewicka, D., Wainscott, D. B., Nelson, D. L., Sanders-Bush, E., & Nichols, D. E. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970219x · Cited by 90
Metabolic fate of mescaline in man
Charalampous, K., Walker, K. E., & Kinross-Wright, J. (1966) · Psychopharmacology · doi:10.1007/bf00427703 · Cited by 88
Evaluation of 3,4-Methylenedioxyamphetamine (MDA) as an Adjunct to Psychotherapy
Naranjo, C. L., Shulgin, A. T., & Sargent, T. (2008) · Medicina et Pharmacologia Experimentalis · doi:10.1159/000137100 · Cited by 86
Screening hallucinogenic drugs: Systematic study of three behavioral tests
Silva, M. T. A., & Calil, H. M. (1975) · Psychopharmacology · doi:10.1007/bf00429548 · Cited by 82
Nichols, D. E., Sassano, M. F., Halberstadt, A. L., Klein, L. M., Brandt, S. D., Elliott, S. P., & Fiedler, W. J. (2015) · ACS Chemical Neuroscience · doi:10.1021/cn500292d · Cited by 80
Sp�th, E. (1919) · Monatshefte für Chemie - Chemical Monthly · doi:10.1007/bf01524590 · Cited by 80
Schlumpberger, B. O., & Renner, S. S. (2012) · American Journal of Botany · doi:10.3732/ajb.1100288 · Cited by 79
Heffter, A. (1898) · Archiv für Experimentelle Pathologie und Pharmakologie · doi:10.1007/bf01825267 · Cited by 77
Agonist-Trafficking and Hallucinogens
Gonzalez-Maeso, J., & Sealfon, S. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709787581851 · Cited by 74
Nichols, D. E., Frescas, S. P., Chemel, B. R., Rehder, K. S., Zhong, D., & Lewin, A. H. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.04.050 · Cited by 74
Geyer, M. A., Petersen, L. R., Rose, G. J., Horwitt, D. D., Light, R. K., Adams, L. M., Zook, J. A., Hawkins, R. L., & Mandell, A. J. (1978) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)31486-2 · Cited by 69
Heffter, A. (1896) · Berichte der deutschen chemischen Gesellschaft · doi:10.1002/cber.18960290145 · Cited by 65
Mescaline and LSD facilitate the activation of locus coeruleus neurons by peripheral stimuli
Aghajanian, G. K. (1980) · Brain Research · doi:10.1016/0006-8993(80)90997-x · Cited by 64
Guitarrero Cave: Early Man in the Andes
Moseley, M. E. (1981) · Hispanic American Historical Review · doi:10.1215/00182168-61.4.790 · Cited by 64
Páleníček, T., Balíková, M., Bubeníková-Valešová, V., & Horáček, J. (2008) · Psychopharmacology · doi:10.1007/s00213-007-0926-5 · Cited by 61
Acute Pharmacological Effects of 2C-B in Humans: An Observational Study
Papaseit, E., Farré, M., Pérez-Mañá, C., Torrens, M., Ventura, M., Pujadas, M., de la Torre, R., & González, D. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00206 · Cited by 59
A characteristic effect of hallucinogens on investigatory responding in rats
Geyer, M. A., Light, R. K., Rose, G. J., Petersen, L. R., Horwitt, D. D., Adams, L. M., & Hawkins, R. L. (1979) · Psychopharmacology · doi:10.1007/bf00491975 · Cited by 57
Ogunbodede, O., McCombs, D., Trout, K., Daley, P. F., & Terry, M. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.07.021 · Cited by 55
A New Hallucinogen: 3,4,5-Trimethoxyphenyl-β-Aminopropane
Peretz, D. I., Smythies, J., & Gibson, W. C. (1955) · Journal of Mental Science · doi:10.1192/bjp.101.423.317 · Cited by 55
Remarks on the Effects of Anhelonium Lewinii (the Mescal Button)
Mitchell, S. W. (1896) · BMJ · doi:10.1136/bmj.2.1875.1625 · Cited by 52
Psychotomimetic agents related to mescaline
Shulgin, A. T. (1963) · Cellular and Molecular Life Sciences · doi:10.1007/bf02171586 · Cited by 46
2,3-Dihydrobenzofuran analogs of hallucinogenic phenethylamines
Nichols, D. E., Snyder, S. E., Oberlender, R., Johnson, M. P., & Huang, X. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00105a043 · Cited by 45
Lower Pecos and Coahuila peyote: new radiocarbon dates
Terry, M., Steelman, K. L., Guilderson, T., Dering, P., & Rowe, M. W. (2006) · Journal of Archaeological Science · doi:10.1016/j.jas.2005.11.008 · Cited by 45
Knauer, A., & Maloney, W. J. M. A. (1913) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-191307000-00001 · Cited by 44
Cactus Alkaloids. I. Trichocereus terscheckii (Parmentier) Britton and Rose
Reti, L., & Castrillón, J. A. R. (1951) · Journal of the American Chemical Society · doi:10.1021/ja01148a097 · Cited by 44
Acute Effects of the Novel Psychoactive Drug 2C-B on Emotions
González, D., Torrens, M., & Farré, M. (2015) · BioMed Research International · doi:10.1155/2015/643878 · Cited by 43
METHYLATION AND DEMETHYLATION IN RELATION TO THE IN VITRO METABOLISM OF MESCALINE
Daly, J. W., Axelrod, J., & Witkop, B. (1962) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1962.tb50099.x · Cited by 39
Heffter, A. (1894) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf01864855 · Cited by 39
Psychotomimetic phenylisopropylamines. 5. 4-Alkyl-2,5-dimethoxyphenylisopropylamines
Shulgin, A. T., & Dyer, D. C. (1975) · Journal of Medicinal Chemistry · doi:10.1021/jm00246a006 · Cited by 38
(I) The Metabolism of Mescalin in the Human (II) Delayed Clinical Reactions to Mescalin
Harley-Mason, J., Laird, A. H., & Smythies, J. (2007) · Confinia Neurologica · doi:10.1159/000105047 · Cited by 38
THE OXIDATION OF MESCALINE AND CERTAIN OTHER AMINES
Bernheim, F., & Bernheim, M. L. C. (1938) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)74180-x · Cited by 37
Nichols, D. E., Hoffman, A. J., Oberlender, R. A., & Riggs, R. M. (1986) · Journal of Medicinal Chemistry · doi:10.1021/jm00152a022 · Cited by 35
Über β‐Phenyl‐äthylamine, I. Mitteil.: Mezcalin und mezcalin‐ähnliche Substanzen
Slotta, K. H., & Heller, H. (1930) · Berichte der deutschen chemischen Gesellschaft (A and B Series) · doi:10.1002/cber.19300631117 · Cited by 35
Involvement of 5-HT receptor subtypes in the discriminative stimulus properties of mescaline
Appel, J. B., & Callahan, P. M. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90041-1 · Cited by 34
Lewin, L. (1888) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf01923627 · Cited by 34
Observations on Taking Peyote "(Anhalonium Lewinii)"
Fernberger, S. W. (1923) · The American Journal of Psychology · doi:10.2307/1413578 · Cited by 34
Chemistry and Pharmacology of Hallucinogens, Entactogens and Stimulants
Kovar, K. ‐. (1998) · Pharmacopsychiatry · doi:10.1055/s-2007-979349 · Cited by 32
Über β‐[Oxyphenyl]‐äthylamine und ihre Umwandlungen, I. Mitteil.: Synthese des Mezcalins
Hahn, G., & Wassmuth, H. (1934) · Berichte der deutschen chemischen Gesellschaft (A and B Series) · doi:10.1002/cber.19340670430 · Cited by 32
Über β‐Phenyl‐äthylamine.III. Mitteilung: Neue Darstellung von Mescalin
Slotta, K. H., & Szyszka, G. (1933) · Journal für praktische Chemie · doi:10.1002/prac.19331370907 · Cited by 31
Über die Reduktion von β‐Nitrostyrolen mit Lithiumaluminiumhydrid
Erne, M., & Ramirez, F. (1950) · Helvetica Chimica Acta · doi:10.1002/hlca.19500330420 · Cited by 29
The chemistry of peyote alkaloids.
KAPADIA, G. J., & Mb, F. (1973) · PubMed · Cited by 27
Ibarra‐Laclette, E., Zamudio-Hernández, F., Pérez-Torres, C., Albert, V. A., Ramírez-Chávez, E., Molina‐Torres, J., Fernández-Cortés, A., Calderón-Vázquez, C. L., Olivares-Romero, J. L., Herrera‐Estrella, A., et al. (2015) · BMC Genomics · doi:10.1186/s12864-015-1821-9 · Cited by 27
Ueber Anhalonium Lewinii und andere Cacteen
Lewin, L. (1894) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf01826536 · Cited by 27 · cited 1×
“Cited by Lewin (1894).”
Tsao, M. U. (1951) · Journal of the American Chemical Society · doi:10.1021/ja01155a562 · Cited by 25
McLean, T. H., Chambers, J. J., Parrish, J. C., Braden, M. R., Marona‐Lewicka, D., Kurrasch‐Orbaugh, D. M., & Nichols, D. E. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060272y · Cited by 24
Mescaline: excitatory effects on acoustic startle are blocked by serotonin2 antagonists
Davis, M. (1987) · Psychopharmacology · doi:10.1007/bf00187244 · Cited by 23
Mescaline elicits behavioral effects in cats by an action at both serotonin and dopamine receptors
Trulson, M. E., Crisp, T., & Henderson, L. J. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90544-7 · Cited by 23
Right hemisphere involvement in mescaline-induced psychosis
Oepen, G., Fünfgeld, M., Harrington, A., Hermle, L., & Botsch, H. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90081-4 · Cited by 22
A complete biosynthetic sequence from tyrosine to mescaline in two cactus species.
Lundström, J., & Agurell, S. (1969) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)99766-1 · Cited by 22
Peroutka, S. J., Hamik, A., Harrington, M. A., Hoffman, A. J., Mathis, C. A., Pierce, P. A., & Wang, S. S.-H. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09783-4 · Cited by 22
Notiz über eine neue Synthese von Mezcalin, N‐Methyl‐ und N‐Dimethylmezcalin
Banholzer, K., Campbell, T. W., & Schmid, H. (1952) · Helvetica Chimica Acta · doi:10.1002/hlca.19520350519 · Cited by 21
Theoretical studies on the interaction of partial agonists with the 5-HT2A receptor
Silva, M. E., Heim, R., Straßer, A., Elz, S., & Dove, S. (2010) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-010-9400-2 · Cited by 21
Aragane, M., Sasaki, Y., Nakajima, J., Fukumori, N., Yoshizawa, M., Suzuki, Y., Kitagawa, S., Mori, K., Ogino, S., Yasuda, I., et al. (2010) · Journal of Natural Medicines · doi:10.1007/s11418-010-0469-7 · Cited by 20
An Improved Synthesis of Mescaline
Benington, F., & Morin, R. D. (1951) · Journal of the American Chemical Society · doi:10.1021/ja01147a505 · Cited by 19
Browne, R. G., Harris, R. T., & HO, B. T. (1974) · Psychopharmacology · doi:10.1007/bf00421457 · Cited by 18
The Pharmacology of Mescaline and D-Lysergic Acid Diethylamide (LSD)
Koelle, G. B. (1958) · New England Journal of Medicine · doi:10.1056/nejm195801022580106 · Cited by 18
Clemente, E. A., & Lynch, V. D. P. (1968) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600570114 · Cited by 18
Kindler, K., & Peschke, W. (1931) · Archiv der Pharmazie · doi:10.1002/ardp.19312693504 · Cited by 18
Reductive Cleavage of Acetals and Ketals with 9-Borabicyclo[3.3.1]nonane
Soderquist, J. A., Kock, I., & Estrella, M. E. (2006) · Organic Process Research & Development · doi:10.1021/op0601262 · Cited by 17
Disposition of 14C-mescaline by rabbit lung.
Roth, R. A., Roth, J. A., & Gillis, C. N. (1977) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30783-4 · Cited by 17
Heffter, A. (1901) · Berichte der deutschen chemischen Gesellschaft · doi:10.1002/cber.190103402266 · Cited by 17
Effect of mescaline on single cortical neurones
Bradshaw, C. M., Roberts, M. H. T., & Szabadi, E. (1971) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1971.tb07225.x · Cited by 16
Notes: The Presence of Mescaline in Opuntia cylindrica
Turner, W. B., & Heyman, J. (1960) · The Journal of Organic Chemistry · doi:10.1021/jo01082a623 · Cited by 16
[Presence of mescaline in a Peruvian Cactaceae].
Poisson, J. E. (1960) · PubMed · Cited by 16
On the similarity between hypnotic and mescaline hallucinations
Halpern, S. L. (1961) · International Journal of Clinical and Experimental Hypnosis · doi:10.1080/00207146108409669 · Cited by 15
Über die Darstellung des Oxymezcalins und Mezcalins 2. Mitteilung
Dornow, A., & Petsch, G. (1952) · Archiv der Pharmazie · doi:10.1002/ardp.19522850704 · Cited by 15
3,4,5-Trimethoxybenzoic acid, a new mescaline metabolite in humans.
Demisch, L., Kaczmarczyk, P., & Seiler, N. (1978) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06273-7 · Cited by 14
Albesiano, S., & Terrazas, T. (2012) · Haseltonia · doi:10.2985/1070-0048-17.1.2 · Cited by 13
Chavín’s Psychoactive Pharmacopoeia:
Torres, C. M. (2008) · Cotsen Institute of Archaeology Press eBooks · doi:10.2307/j.ctvdmwx21.15 · Cited by 13
Kindler, K., & Peschke, W. (1932) · Archiv der Pharmazie · doi:10.1002/ardp.19322700709 · Cited by 12
Versuche zur Synthese des Mezcalins
Heffter, A., & Capellmann, R. (1905) · Berichte der deutschen chemischen Gesellschaft · doi:10.1002/cber.190503803208 · Cited by 12
Klein, M. T., Kalam, M., Trout, K., Fowler, N. L., & Terry, M. (2015) · Haseltonia · doi:10.2985/026.020.0107 · Cited by 12
Heffter, A. (1898) · Berichte der deutschen chemischen Gesellschaft · doi:10.1002/cber.189803101217 · Cited by 12
Cactus Alkaloids and Some Related Compounds
Reti, L. (1950) · Springer eBooks · doi:10.1007/978-3-7091-7175-2_4 · Cited by 11
Mescaline-induced motor impairment in rats, assessed by two different methods
Sykes, E. A. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90196-7 · Cited by 11
INTERACTIONS OF HALLUCINOGENS AT THE CLINICAL LEVEL
Wyatt, R. J., Cannon, E., Stoff, D. M., & Gillin, J. C. (1976) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1976.tb27952.x · Cited by 11
Versuche mit Meskalin an Halluzinanten
Zucker, K. (1930) · Zeitschrift für die gesamte Neurologie und Psychiatrie · doi:10.1007/bf02864200 · Cited by 11
Buchanan, D. N. (1929) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1929.tb01395.x · Cited by 11
Discriminative stimulus properties of mescaline: Mescaline or metabolite?
Browne, R. G., & Ho, B. T. (1975) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(75)90088-x · Cited by 10
Tierversuche mit 14C‐radioaktivem Mescalin und sein Einbau in das Eiweiß der Leber
Block, W., & Block, K. (1952) · Angewandte Chemie · doi:10.1002/ange.19520640608 · Cited by 10
Mescaline synthesis via tricarbonyl (η6-1,2,3-trimethoxybenzene)chromium complex
Rose‐Munch, F., Chavignon, R., Tranchier, J., Gagliardini, V., & Rose, É. (2000) · Inorganica Chimica Acta · doi:10.1016/s0020-1693(00)00011-6 · Cited by 7
HALLUCINATION AND IMAGERY INDUCED BY MESCALINE
THALE, T., Gabrio, B. W., & Salomon, K. (1950) · American Journal of Psychiatry · doi:10.1176/ajp.106.9.686 · Cited by 6
Chemical Psychoses: LSD and Related Drugs
Hayman, M. (1969) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1969.23.4.722 · Cited by 6
Apparent intermediates in the biosynthesis of mescaline and related tetrahydroisoquinolines
Agurell, S., & Lundström, J. (1968) · Chemical Communications (London) · doi:10.1039/c1968001638b · Cited by 4
Albesiano, S., & Kiesling, R. (2012) · Haseltonia · doi:10.2985/1070-0048-17.1.3 · Cited by 4
Variierte Serien versuche mit Meskalin
Franke, G. (1934) · Zeitschrift für die gesamte Neurologie und Psychiatrie · doi:10.1007/bf02890923 · Cited by 1
Research works printed but not linked: 12
- Torres C. M., 2008, Chavín Art, Architecture and Culture, 237
- Sahagún B., Historia General de las Cosas de la Nueva España
- Sharon D., 1972, Flesh of the Gods. The Ritual Use of Hallucinogens, 114
- Cruz-Sánchez G., 1948, Rev. Farmacología Med. Exp., 1, 143
- Gutiérrez-Noriega C., 1050, América Indígena, 10, 215
- Poisson J., 1960, Ann. pharm. franç, 18, 764
- Hulsey D., 2011, J. Bot. Res. Inst. Texas, 5, 677
- Kapadia G. J., 1973, Lloydia, 36, 9
- Prentiss D. W., 1895, Ther. Gazette, 9, 577
- Ellis H., 1898, Contemp. Rev., 73, 130
- Shulgin A. T., 1991, PIHKAL, Phenethylamines I Have Known and Loved. A Chemical Love Story
- Alles G. A., 1957, Neuropharmacology, Trans. 4th Conf.
Cited by
The promises and perils of psychedelic pharmacology for psychiatry
McClure-Begley, T. D., & Roth, B. L. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00421-7 · Cited by 194
General and specialized tyrosine metabolism pathways in plants
Xu, J.-J., Fang, X., Li, C., Yang, L., & Chen, X. (2019) · aBIOTECH · doi:10.1007/s42994-019-00006-w · Cited by 152
Dinis-Oliveira, R. J., Pereira, C. L., & da Silva, D. D. (2019) · Current Molecular Pharmacology · doi:10.2174/1874467211666181010154139 · Cited by 100
Mescaline: The forgotten psychedelic
Vamvakopoulou, I. A., Narine, K. A. D., Campbell, I., Dyck, J. R. B., & Nutt, D. J. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109294 · Cited by 121
“Mescaline also binds to the dopamine (DAT), norepinephrine (NET), and serotonin (SERT) transporters but with lower affinity (Table 1) (Páleníček et al., 2008; Kyzar et al., 2012; Rickli et al., 2016; Cassels and Sáez-Briones, 2018).”
BackgroundInfluentialDuan, W., Cao, D., Wang, S., & Cheng, J. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00375 · Cited by 85
Metadata
- Authors
- Cassels, B. K., & Sáez-Briones, P.
- Affiliations
- University of Chile (CL)
- Laboratory of Neuropharmacology and Behavior, School of Medicine, Faculty of Medical Sciences, Universidad de Santiago de Chile, Santiago 9170022, Chile
- Corresponding author
- Cassels, Bruce K.
- ORCID
- Cassels, Bruce K.
- Venue
- ACS Chemical Neuroscience
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-05-30
- Volume
- 9
- Issue
- 10
- Pages
- 2448-2458
- ISSN
- 1948-7193 (ISSN-L)
- OpenAlex
- W2806747726
- Cited by
- 85
- References
- 126
- Citations by year
- 2026: 3 · 2025: 13 · 2024: 12 · 2023: 25 · 2022: 14 · 2021: 11 · 2020: 3 · 2019: 3 · 2018: 1
- FWCI
- 0.76
- Type
- journal article
- Language
- en
- Open access
- Licence
- cc-by-nc-nd
- Locations
- ACS Chemical Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Universidad de Chile (submittedVersion, cc-by-nc-nd)
- Funders
- Departamento de Investigaciones Cient?ficas y Tecnol?gicas, Universidad de Santiago de Chile (021701SB)
- Fondo Nacional de Desarrollo Cient?fico y Tecnol?gico (1150686)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Alkaloids: synthesis and pharmacology
- Physical Sciences › Chemistry › Organic Chemistry › Synthesis and bioactivity of alkaloids
- Keywords
- mescaline, peyote, Lophophora williamsii, cactus alkaloids, psychedelics, 5-HT2A receptor agonism, 5-HT1A receptor, alpha2A-adrenergic receptor, structure-activity relationship
- MeSH terms
- Hallucinogens, Humans, Mescaline, Structure-Activity Relationship, History, 16th Century, History, 19th Century, History, 20th Century, History, 21st Century, History, Ancient
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.